Partnership Aims to Tackle Diabetes Among Latinos
Lilly plans to present trial results at scientific meetings and publications this year and in 2016.
Subscriber Benefit
As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe NowIndianapolis-based Eli Lilly & Co. (NYSE: LLY) has announced a research collaboration with the William Sansum Diabetes Center in California. The pharmaceutical company says the partnership aims to improve the lives of Latino people affected by diabetes.
Lilly says the collaboration will provide insight into the unmet needs of Latino diabetes patients and help with the development of interventions that could improve health outcomes.
"This is a great opportunity for us to further understand the significant impact of diabetes for Latino families," said Dara Schuster, senior director of U.S. Medical Affairs for Lilly Diabetes. "Through this collaboration, we will learn where the gaps are so we can develop meaningful solutions for the unmet needs."
David Kerr, director of innovation and research for the William Sansum Diabetes Center, says Latino people comprise 43 percent of the total population in Santa Barbara County in California, where the center is based. He says rates of cardio-metabolic disease are much higher than the rest of the population.
"The tremendous burden of diabetes and cardiovascular disease bears a disproportionate weight on Latino families in the United States," said David Kerr, director of Innovation and Research for the William Sansum Diabetes Center. "This collaboration with Lilly will allow us to gain a better understanding of how we can help these families."
The partners say the collaboration will result in enhanced research, education and care.